OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroactive Peptides as Putative Mediators of Antiepileptic Ketogenic Diets
Carmela Giordano, Maddalena MarchiÃ, Elena Timofeeva, et al.
Frontiers in Neurology (2014) Vol. 5
Open Access | Times Cited: 114

Showing 26-50 of 114 citing articles:

Repeated 6-Hz Corneal Stimulation Progressively Increases FosB/ΔFosB Levels in the Lateral Amygdala and Induces Seizure Generalization to the Hippocampus
Carmela Giordano, Jonathan Vinet, Giulia Curia, et al.
PLoS ONE (2015) Vol. 10, Iss. 11, pp. e0141221-e0141221
Open Access | Times Cited: 42

Rational Design of Hybrid Peptides: A Novel Drug Design Approach
Chao Wang, Chen Yang, Yuchen Chen, et al.
Current Medical Science (2019) Vol. 39, Iss. 3, pp. 349-355
Closed Access | Times Cited: 42

Main methods and tools for peptide development based on protein-protein interactions (PPIs).
Javiera Baeza, Mauricio Bedoya, Pablo Cruz, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151623-151623
Closed Access

Peptide-Based Therapeutics in Cancer Therapy
Abduladheem Turki Jalil, Mohanad Ali Abdulhadi, Lubna R. Al-Ameer, et al.
Molecular Biotechnology (2023) Vol. 66, Iss. 10, pp. 2679-2696
Closed Access | Times Cited: 9

Current Research on Antiepileptic Compounds
Cheng‐Xi Wei, Ming Bian, Guo-Hua Gong
Molecules (2015) Vol. 20, Iss. 11, pp. 20741-20776
Open Access | Times Cited: 33

The changing face of dietary therapy for epilepsy
Ludovica Pasca, Valentina De Giorgis, Joyce Ann Macasaet, et al.
European Journal of Pediatrics (2016) Vol. 175, Iss. 10, pp. 1267-1276
Closed Access | Times Cited: 29

Decreased ghrelin and des-acyl ghrelin plasma levels in patients affected by pharmacoresistant epilepsy and maintained on the ketogenic diet
Maddalena Marchiò, Laura Roli, Carmela Giordano, et al.
Clinical Nutrition (2018) Vol. 38, Iss. 2, pp. 954-957
Closed Access | Times Cited: 29

Overview of intranasally delivered peptides: key considerations for pharmaceutical development
Wisam Al Bakri, Maureen D. Donovan, Maria A. Cueto, et al.
Expert Opinion on Drug Delivery (2018) Vol. 15, Iss. 10, pp. 991-1005
Closed Access | Times Cited: 29

Teixobactin: A Paving Stone toward a New Class of Antibiotics?
Vidya B. Gunjal, Ritesh P. Thakare, Sidharth Chopra, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 21, pp. 12171-12195
Closed Access | Times Cited: 26

A prospective study on changes in blood levels of cholecystokinin-8 and leptin in patients with refractory epilepsy treated with the ketogenic diet
Danielle A.J.E. Lambrechts, Evelyn Brandt‐Wouters, Pauline Verschuure, et al.
Epilepsy Research (2016) Vol. 127, pp. 87-92
Closed Access | Times Cited: 25

Ghrelin Plasma Levels After 1 Year of Ketogenic Diet in Children With Refractory Epilepsy
Maddalena Marchiò, Laura Roli, Chiara Lucchi, et al.
Frontiers in Nutrition (2019) Vol. 6
Open Access | Times Cited: 23

Neuropeptide Y Y2 and Y5 receptors as potential targets for neuroprotective and antidepressant therapies: Evidence from preclinical studies
Helena Domin
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 111, pp. 110349-110349
Closed Access | Times Cited: 19

Intracellular delivery of Parkin-RING0-based fragments corrects Parkin-induced mitochondrial dysfunction through interaction with SLP-2
Alessandra Zanon, Marianna Guida, Alexandros Α. Lavdas, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2

Recent Advances in Pharmaceutical Design: Unleashing the Potential of Novel Therapeutics
Ram Narayan Prajapati, Bharat Bhushan, Kuldeep Singh, et al.
Current Pharmaceutical Biotechnology (2024) Vol. 25, Iss. 16, pp. 2060-2077
Closed Access | Times Cited: 2

Biphasic effect of sumatriptan on PTZ-induced seizures in mice: Modulation by 5-HT1B/D receptors and NOS/NO pathway
Maziar Gooshe, Keyvan Ghasemi, Mohammad Rohani, et al.
European Journal of Pharmacology (2018) Vol. 824, pp. 140-147
Open Access | Times Cited: 23

Altered Proteins in the Hippocampus of Patients with Mesial Temporal Lobe Epilepsy
Daniele Suzete Persike, José Eduardo Marques Carneiro da Silva, Mariana Stein, et al.
Pharmaceuticals (2018) Vol. 11, Iss. 4, pp. 95-95
Open Access | Times Cited: 23

Food and Food Products on the Italian Market for Ketogenic Dietary Treatment of Neurological Diseases
Alessandro Leone, Ramona De Amicis, Chiara Lessa, et al.
Nutrients (2019) Vol. 11, Iss. 5, pp. 1104-1104
Open Access | Times Cited: 21

The CB2 Receptor as a Novel Therapeutic Target for Epilepsy Treatment
Xiaoyu Ji, Yang Zeng, Jie Wu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8961-8961
Open Access | Times Cited: 17

Ketogenic Diets and their Therapeutic Potential on Breast Cancer: A Systemic Review
Mohammed Jemal, Tewodros Shibabaw, Tadesse Asmamaw Dejenie
Cancer Management and Research (2021) Vol. Volume 13, pp. 9147-9155
Open Access | Times Cited: 17

Scroll to top